TSX VENTURE COMPANIES
MEDEXUS PHARMACEUTICALS INC. ("MDP")
[formerly PEDIAPHARM INC. ("PDP")]
BULLETIN TYPE: Name Change and Consolidation
BULLETIN DATE: December 17, 2018
TSX Venture Tier 2 Company
Pursuant to a resolution passed by shareholders December 12, 2018, the Company has consolidated its capital on a (15) fifteen old for (1) one new basis. The name of the Company has also been changed as follows.
Effective at the opening December 19, 2018, the common shares of Medexus Pharmaceuticals Inc. will commence trading on TSX Venture Exchange, and the common shares of Pediapharm Inc. will be delisted. The Company is classified as a 'Pharmaceutical And Medicine Manufacturing' company.
Post - Consolidation
Capitalization: Unlimited shares with no par value of which
14,746,258 shares are issued and outstanding
Escrow: Nil shares are subject to escrow
Transfer Agent: Computershare Trust Company of Canada
Trading Symbol: MDP (new)
CUSIP Number: 58410Q203 (new)
58410Q104 (unlisted shares - 4 month hold restriction)
________________________________________
|
|
